Skip to main content
. 2010 Oct 20;2011:425923. doi: 10.4061/2011/425923

Table 2.

Changes in cardiac biomarkers, oxidative stress, and various cardiovascular imaging parameters compared between the high and low ischemia (number of inducible myocardial perfusion defects) groups.

Study variable High inducible ischemia (n = 18) Low inducible ischemia (n = 16) P value
Laboratory
 Creatinine (μmol/L)—at rest 86.0 ± 27.2 75.6 ± 16.6 .19
 Creatinine (μmol/L)—with stress 88.2 ± 28.6 78.5 ± 18.0 .25
 ΔCreatinine (μmol/L) 2.2 ± 7.3 2.9 ± 8.0 .80
 BNP (pg/mL)—at rest 80.3 ± 60.6 52.9 ± 43.9 .15
 BNP (pg/mL)—with stress 92.1 ± 68.8 56.8 ± 40.3 .08
 ΔBNP (pg/mL) 11.8 ± 11.8 3.8 ± 7.2 .02
 cTnI (μg/L)—at rest 0.010 ± 0.009 0.008 ± 0.007 .45
 cTnI (μg/L)—with stress 0.016 ± 0.014 0.008 ± 0.007 .05
 ΔcTnI (μg/L) 0.007 ± 0.013 0.002 ± 0.004 .16
 NT-proBNP (pg/mL)—at rest 580.4 ± 712.9 289.9 ± 215.8 .13
 NT-proBNP (pg/mL)—with stress 639.5 ± 754.1 294.9 ± 204.3 .08
 ΔNT-proBNP (pg/mL) 59.1 ± 84.9 5.0 ± 48.8 .03
 AOPP (μmol/L)—at rest 121.2 ± 116.3 77.0 ± 28.5 .15
 AOPP (μmol/L)—with stress 95.0 ± 102.2 65.2 ± 18.6 .26
 ΔAOPP (μmol/L) −26.1 ± 49.4 −11.8 ± 26.2 .29
Cardiovascular parameters
 Segmental perfusion defects—at rest 3.8 ± 5.5 1.8 ± 3.5 .22
 Segmental perfusion defects—with stress 10.7 ± 7.1 2.6 ± 4.0 <.001
 ΔSegmental perfusion defects 6.6 ± 3.0 0.8 ± 0.8 <.001
 End diastolic volume (mL)—at rest 101.3 ± 29.7 105.2 ± 27.9 .70
 End diastolic volume (mL)—with stress 107.8 ± 36.7 102.2 ± 27.4 .63
 ΔEnd diastolic volume (mL) 6.5 ± 10.9 0.1 ± 8.8 .07
 End systolic volume (mL)—at rest 46.5 ± 24.5 43.8 ± 19.1 .73
 End systolic volume (mL)—with stress 51.1 ± 30.4 42.3 ± 19.7 .34
 ΔEnd systolic volume (mL) 4.6 ± 8.7 0.4 ± 8.6 .19
 Ejection fraction (%)—at rest 56.7 ± 10.6 61.1 ± 12.1 .27
 Ejection fraction (%)—with stress 55.6 ± 11.6 60.6 ± 11.0 .21
 ΔEjection fraction (%) −1.1 ± 3.9 −0.5 ± 6.1 .74

Δ: delta (change from pre-stress to poststress test).

BNP: B-type natriuretic peptide, cTnI: cardiac troponin I, NT-proBNP: N-terminal-pro-B-type natriuretic peptide, AOPP: advanced oxidation protein products, NGAL: neutrophil gelatinase-associated lipocalin.